Vulnerability in Smiths-Medical Medfusion 4000 Wireless Syringe Infusion Pump
CVE-2017-12721
An Improper Certificate Validation issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The pump does not validate host certificates, leaving the pump vulnerable to a man-in-the-middle (MITM) attack.
Vulnerability class: Improper Certificate Validation
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.9 (Medium). Vector: CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N.
EPSS exploit prediction
EPSS: 0.007 (50.3th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 50th percentile — 50.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000
Affected products
- Smiths-Medical Medfusion 4000 Wireless Syringe Infusion Pump — versions 1.1, 1.5, 1.6
- Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump — versions Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump
Weakness classification (CWE)
References
- ics-cert.us-cert.gov/advisories/ICSMA-17-250-02A (US Government Resource, Third Party Advisory)
- www.securityfocus.com/bid/100665 (VDB Entry, Third Party Advisory, vdb-entry)
Frequently asked questions
- What is CVE-2017-12721?
- CVE-2017-12721 is a medium-severity vulnerability in Smiths-Medical Medfusion 4000 Wireless Syringe Infusion Pump, classified under Improper Certificate Validation. CVSS score: 5.9/10. Published 2018-02-15.
- How severe is CVE-2017-12721?
- Medium severity. CVSS v3 base score is 5.9 out of 10.